Search - tctmd.com

Displaying 21 - 40 of 2970

Sort: Relevancy | Date

Presentation TCT 2025

TCT 1753: IVUS Guided LMCA True Bifurcation Medina 1,1,1 Double Kiss Crush Angioplasty and Two Stents to Mid Lad and Left Circumflex in Stage 5 Chronic Kidney Disease

Presenter: Binoy John

October 27, 2025

Presentation TCT 2025

TCT 468: Comparison of Limus and Paclitaxel Drug-Coated Balloons, 2nd-generation or Newer Drug-Eluting Stents, and Balloon Angioplasty: A Network Meta-Analysis of Randomized Controlled Trials

Presenter: Yuko Kiyohara

October 27, 2025

Presentation TCT 2025

TCT 430: Photon-Counting Detector Computed Tomography for the Assessment of Coronary Stents and In-Stent Restenosis

Presenter: Doosup Shin

October 27, 2025

Presentation TCT 2025

TCT 511: Paclitaxel-Coated Balloons versus Newer-Generation Drug-Eluting Stents for De Novo Coronary Artery Lesions: A Meta-Analysis of Randomized Controlled Trials

Presenter: Kamil Bujak

October 27, 2025

Presentation TCT 2025

TCT 502: Drug-Coated Balloons Versus Drug-Eluting Stents for Patients with Diffuse De Novo Coronary Artery Lesions: Insights from the REC-CAGEFREE I Trial

Presenter: Yuehao Lv

October 27, 2025

Presentation TCT 2025

TCT 503: Impact of sex on outcomes in patients treated with drug-coated balloons versus drug-eluting stents for de novo coronary artery lesions: Insights from the REC-CAGEFREE I trial

Presenter: Ping Wang

October 27, 2025

Presentation TCT 2025

TCT 500: Clinical Outcomes of Patients With ST-Elevation Myocardial Infarction Treated With Drug-coated Balloons, Hybrid Strategies, or Drug-eluting Stents

Presenter: Nancy Virginia

October 27, 2025

Presentation TCT 2025

TCT 1856: So Many Layers of Stents and an Aneurysm: What Can You Do?

Presenter: Elias Sanidas

October 27, 2025

News Conference News TCT 2025

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

Michael O'Riordan

October 26, 2025

Presentation TCT 2025

TCT 235: Efficacy of Bioresorbable Vascular Scaffold vs Drug-Eluting Stents After PCI : A GRADE-Assessed Systematic Review and Meta-Analysis of Randomised Controlled Trials

Presenter: Sultana Jahan

October 26, 2025

Presentation TCT 2025

Closing Thoughts

Presenter: Robert W. Yeh

October 26, 2025

Presentation TCT 2025

Case Discussion

Presenter: Robert W. Yeh

October 26, 2025

Presentation TCT 2025

Case Presentation: Outcomes with Bioadaptor in Complex PCI

Presenter: Tamil Selvan Muthusamy

October 26, 2025

Presentation TCT 2025

Case Presentation: Long-Term Follow Up in LAD Disease and Computational Analysis

Presenter: Daniela Benedetto

October 26, 2025

Presentation TCT 2025

Panel Discussion: Why Does the MOA of Bioadaptor Matter? Impact on Patients Outcomes in PCI

Presenter: Robert W. Yeh

October 26, 2025

Presentation TCT 2025

BIOADAPTOR-RCT 3 Year Outcomes and Bioadaptor Mechanism of Action

Presenter: Johan R. Bennett

October 26, 2025

Presentation TCT 2025

INFINITY-SWEDEHEART-RCT 1 Year Clinical Outcomes

Presenter: David Erlinge

October 26, 2025

Presentation TCT 2025

Current Status of Long-Term PCI Outcomes: Why it is Time to Rethink PCI Success

Presenter: David J. Cohen

October 26, 2025

Presentation TCT 2025

Welcone & Introductions

Presenter: Shigeru Saito

October 26, 2025

Presentation TCT 2025

TCT 189: Follow-up of Flow-Reserve-Guided Treatment for In-Stent Restenosis of Drug-Eluting Coronary Stents

Presenter: Kornel Kakonyi

October 26, 2025

Advertisement

TCT 1753: IVUS Guided LMCA True Bifurcation Medina 1,1,1 Double Kiss Crush Angioplasty and Two Stents to Mid Lad and Left Circumflex in Stage 5 Chronic Kidney Disease

TCT 468: Comparison of Limus and Paclitaxel Drug-Coated Balloons, 2nd-generation or Newer Drug-Eluting Stents, and Balloon Angioplasty: A Network Meta-Analysis of Randomized Controlled Trials

TCT 430: Photon-Counting Detector Computed Tomography for the Assessment of Coronary Stents and In-Stent Restenosis

TCT 511: Paclitaxel-Coated Balloons versus Newer-Generation Drug-Eluting Stents for De Novo Coronary Artery Lesions: A Meta-Analysis of Randomized Controlled Trials

TCT 502: Drug-Coated Balloons Versus Drug-Eluting Stents for Patients with Diffuse De Novo Coronary Artery Lesions: Insights from the REC-CAGEFREE I Trial

TCT 503: Impact of sex on outcomes in patients treated with drug-coated balloons versus drug-eluting stents for de novo coronary artery lesions: Insights from the REC-CAGEFREE I trial

TCT 500: Clinical Outcomes of Patients With ST-Elevation Myocardial Infarction Treated With Drug-coated Balloons, Hybrid Strategies, or Drug-eluting Stents

TCT 1856: So Many Layers of Stents and an Aneurysm: What Can You Do?

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

TCT 235: Efficacy of Bioresorbable Vascular Scaffold vs Drug-Eluting Stents After PCI : A GRADE-Assessed Systematic Review and Meta-Analysis of Randomised Controlled Trials

Closing Thoughts

Case Discussion

Case Presentation: Outcomes with Bioadaptor in Complex PCI

Case Presentation: Long-Term Follow Up in LAD Disease and Computational Analysis

Panel Discussion: Why Does the MOA of Bioadaptor Matter? Impact on Patients Outcomes in PCI

BIOADAPTOR-RCT 3 Year Outcomes and Bioadaptor Mechanism of Action

INFINITY-SWEDEHEART-RCT 1 Year Clinical Outcomes

Current Status of Long-Term PCI Outcomes: Why it is Time to Rethink PCI Success

Welcone & Introductions

TCT 189: Follow-up of Flow-Reserve-Guided Treatment for In-Stent Restenosis of Drug-Eluting Coronary Stents

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content